-+ 0.00%
-+ 0.00%
-+ 0.00%

CASI Pharmaceuticals Q1 EPS $(0.69) Misses $(0.61) Estimate, Sales $6.24M Beat $6.10M Estimate

Benzinga·05/16/2025 22:06:09
Listen to the news
CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.61) by 13.11 percent. This is a 2.82 percent increase over losses of $(0.71) per share from the same period last year. The company reported quarterly sales of $6.24 million which beat the analyst consensus estimate of $6.10 million by 2.30 percent. This is a 83.04 percent increase over sales of $3.41 million the same period last year.